Lupus Research Alliance collaborates with Bristol-Myers Squibb to study BMS-986165 for lupus April 27, 2018
Neuraltus' NP-001 safe and well tolerated but does not slow disease progression in ALS April 27, 2018
Vertex initiates phase III studies of VX-445, tezacaftor and ivacaftor in cystic fibrosis April 27, 2018
FDA grants breakthrough therapy designation to OMS-721 for HSCT thrombotic microangiopathy April 27, 2018
RSS